This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Conflict of Interest  • Medical Education  • Medical Ethics  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

New Policies Needed Now on Interactions Between Pharmaceutical Companies and Physicians

Philip Greenland, MD

Arch Intern Med. 2009;169(9):829-831.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

On January 1, 2009, the Pharmaceutical Research and Manufacturers of America¹ enacted a new code governing the interactions between pharmaceutical company representatives and health care professionals. The new code, while voluntary for the pharmaceutical manufacturers and physicians, has been endorsed by more than 30 major companies, and it will eliminate small gifts to physicians such as the familiar logo-embossed pens and coffee mugs. The new code, however, does not prohibit sponsorship of office-based or hospital-based meals, continuing medical education (CME) events, or other forms of marketing contacts that are also exceedingly common. Blumenthal² noted in 2004 that over 90% of physicians in the United States reported at least 1 yearly interaction with a pharmaceutical company, typically in the course of an office "detailing" visit or a CME event. Wazana³ reported in 2000 that, on average, practicing physicians met with drug company representatives 4 times a month. Thus, . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Are We Providers or Physicians?
J. David Baxter
Arch Intern Med. 2009;169(18):1725.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences
David Grande, Dominick L. Frosch, Andrew W. Perkins, and Barbara E. Kahn
Arch Intern Med. 2009;169(9):887-893.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Are We Providers or Physicians?
Baxter
Arch Intern Med 2009;169:1725-1725.
FULL TEXT